{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T14:56:29Z","timestamp":1782831389720,"version":"3.54.5"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T00:00:00Z","timestamp":1619049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>In recent years, evidence that aldosteronism is a risk factor for metabolic disorders has increased. This study was designed to investigate the role of nonalcoholic fatty liver disease (NAFLD) and hypokalemia in primary aldosteronism (PA).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A total of 222 patients diagnosed with PA and 222 non-PA patients were included in our study. Demographic data, medical histories, clinical evaluations, complete blood counts, serum biochemical analyses, aldosterone and potassium levels were obtained. Data are presented as the means \u00b1 standard deviation (SD). To compare the parameters between cases and controls, Student\u2019s t-tests or Mann-Whitney U tests were used for continuous variables, and \u03c72 tests were used for categorical variables. Pearson correlation analysis was used to define relationships between pairs of parameters. A two-sided <jats:italic>P<\/jats:italic> &amp;lt; 0.05 was considered statistically significant. Multivariate logistic regression was performed to assess the independent effects of potassium and other metabolic variables on NAFLD in PA patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The diagnosis of NAFLD was more common in PA patients (n=222, 35.1%) than in non-PA subjects (29.7%). PA patients with and without NAFLD had similar metabolic imbalance characteristics. In PA patients with hypokalemia, relatively higher prevalences of NAFLD (44% vs. 27%, <jats:italic>P<\/jats:italic> &amp;lt; 0.05) and diabetes mellitus (19.8% vs. 9.9%, <jats:italic>P<\/jats:italic> &amp;lt; 0.05) were observed. Hypokalemic PA patients had a worse metabolic status than PA patients without hypokalemia, including higher body mass index (BMI) (25.4 \u00b1 3.4 vs. 24.1 \u00b1 3.9 kg\/m<jats:sup>2<\/jats:sup>, <jats:italic>P<\/jats:italic> &amp;lt; 0.05), more severe dyslipidemia as well as insulin resistance, higher serum uric acid levels (354 \u00b1 95 vs. 319 \u00b1 87 \u03bcmol\/L, <jats:italic>P<\/jats:italic> &amp;lt; 0.01) and aggravated inflammation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The prevalence of NAFLD was higher in PA patients than in non-PA patients, although the patterns of obesity, dyslipidemia and insulin resistance were similar. Hypokalemic PA patients had a worse metabolic status than normokalemic PA patients. This study provides new insights that can inform further mechanistic studies about metabolic imbalance in patients with aldosteronism.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2021.565714","type":"journal-article","created":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T15:55:59Z","timestamp":1619106959000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Non-Alcoholic Fatty Liver Disease and Hypokalemia in Primary Aldosteronism Among Chinese Population"],"prefix":"10.3389","volume":"12","author":[{"given":"Yi","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaohui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,4,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.steroids.2014.08.016","article-title":"Effects of aldosterone on insulin sensitivity and secretion","volume":"91","author":"Luther","year":"2014","journal-title":"Steroids"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196511182732106","article-title":"Hypertension, the potassium ion and impaired carbohydrate tolerance","volume":"273","author":"Conn","year":"1965","journal-title":"New Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-011-2158-9","article-title":"Aldosterone decreases glucose-stimulated insulin secretion in vivo in mice and in murine islets","volume":"54","author":"Luther","year":"2011","journal-title":"Diabetologia"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa065061","article-title":"Effect of ramipril on the incidence of diabetes","volume":"355","author":"Bosch","year":"2006","journal-title":"New Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1001121","article-title":"Effect of valsartan on the incidence of diabetes and cardiovascular events","volume":"362","author":"McMurray","year":"2010","journal-title":"New Engl J Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/j.1751-2980.2010.00476.x","article-title":"Guidelines for the diagnosis and management of nonalcoholic fatty liver disease: update 2010: (published in Chinese on Chinese Journal of Hepatology 2010; 18:163-166)","volume":"12","author":"Fan","year":"2011","journal-title":"J Dig Dis"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1055\/s-0035-1562943","article-title":"Epidemiology and Natural History of Nonalcoholic Fatty Liver Disease","volume":"35","author":"Satapathy","year":"2015","journal-title":"Semin Liver Dis"},{"key":"B8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"g4596","DOI":"10.1136\/bmj.g4596","article-title":"Non-alcoholic fatty liver disease","volume":"349","author":"Sattar","year":"2014","journal-title":"BMJ (Clin Res ed)"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(98)70599-2","article-title":"Steatohepatitis: a tale of two \u201chits\u201d","volume":"114","author":"Day","year":"1998","journal-title":"Gastroenterology"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.12.012","article-title":"NAFLD: a multisystem disease","volume":"62","author":"Byrne","year":"2015","journal-title":"J Hepatol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v24.i27.2974","article-title":"Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: From \u201ctwo hit theory\u201d to \u201cmultiple hit model\u201d","volume":"24","author":"Fang","year":"2018","journal-title":"World J Gastroenterol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/j.1463-1326.2011.01403.x","article-title":"Current therapeutic strategies in non-alcoholic fatty liver disease","volume":"13","author":"Dowman","year":"2011","journal-title":"Diabetes Obes Metab"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v21.i39.11053","article-title":"Endocrine causes of nonalcoholic fatty liver disease","volume":"21","author":"Marino","year":"2015","journal-title":"World J Gastroenterol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.14105","article-title":"Risk for the development of non-alcoholic fatty liver disease: A prospective study","volume":"33","author":"Wang","year":"2018","journal-title":"J Gastroenterol Hepatol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"23279","DOI":"10.1038\/srep23279","article-title":"Serum complement C3 levels are associated with nonalcoholic fatty liver disease independently of metabolic features in Chinese population","volume":"6","author":"Xu","year":"2016","journal-title":"Sci Rep"},{"key":"B17","doi-asserted-by":"publisher","first-page":"16494","DOI":"10.1038\/srep16494","article-title":"ZJU index: a novel model for predicting nonalcoholic fatty liver disease in a Chinese population","volume":"5","author":"Wang","year":"2015","journal-title":"Sci Rep"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-1733","article-title":"Prevalence and characteristics of the metabolic syndrome in primary aldosteronism","volume":"91","author":"Fallo","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-4061","article-title":"The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/ajh.2009.206","article-title":"Nonalcoholic fatty liver disease in primary aldosteronism: a pilot study","volume":"23","author":"Fallo","year":"2010","journal-title":"Am J Hypertens"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(19)30039-1","article-title":"Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis","volume":"4","author":"Li","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0000000000001191","article-title":"Non-alcoholic fatty liver disease and hypertension: coprevalent or correlated","volume":"30","author":"Oikonomou","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.25.1.30","article-title":"Relationships among plasma aldosterone, high-density lipoprotein cholesterol, and insulin in humans","volume":"25","author":"Goodfriend","year":"1995","journal-title":"Hypertens (Dallas Tex 1979)"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm_00000480","article-title":"Selective aldosterone blocker ameliorates the progression of non-alcoholic steatohepatitis in rats","volume":"26","author":"Noguchi","year":"2010","journal-title":"Int J Mol Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.12008","article-title":"Dual blockade of angiotensin-II and aldosterone suppresses the progression of a non-diabetic rat model of steatohepatitis","volume":"43","author":"Noguchi","year":"2013","journal-title":"Hepatol Res Off J Jpn Soc Hepatol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-0736","article-title":"Insulin sensitivity in patients with primary aldosteronism: a follow-up study","volume":"91","author":"Catena","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2017.08.010","article-title":"Nonalcoholic Fatty Liver Disease and Metabolic Syndrome","volume":"22","author":"Kim","year":"2018","journal-title":"Clinics Liver Dis"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-003-0065-2","article-title":"The effect of aldosterone on glucose metabolism","volume":"5","author":"Corry","year":"2003","journal-title":"Curr Hypertens Rep"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2010.01.007","article-title":"Insulin resistance and metabolic syndrome in patients with nonfunctioning adrenal incidentalomas: a cause-effect relationship","volume":"59","author":"Peppa","year":"2010","journal-title":"Metab: Clin Exp"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1055\/s-0031-1295412","article-title":"Primary aldosteronism and metabolic syndrome","volume":"44","author":"Fallo","year":"2012","journal-title":"Horm Metab Res  Horm  Stoffwechselforschung  Horm Metab"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-0760(03)00072-4","article-title":"Transcriptional inhibition of the human insulin receptor gene by aldosterone","volume":"84","author":"Calle","year":"2003","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1210\/js.2017-00055","article-title":"Fatty Liver Disease, Women, and Aldosterone: Finding a Link in the Jackson Heart Study","volume":"1","author":"Kumar","year":"2017","journal-title":"J Endocr Soc"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2013.07.010","article-title":"Serum potassium level is associated with metabolic syndrome: a population-based study","volume":"33","author":"Sun","year":"2014","journal-title":"Clin Nutr (Edinb Scotland)"},{"key":"B34","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.mce.2012.04.013","article-title":"The role of angiotensin II in nonalcoholic steatohepatitis","volume":"378","author":"Matthew Morris","year":"2013","journal-title":"Mol Cell Endocrinol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s12944-018-0824-3","article-title":"Resveratrol ameliorates maternal and post-weaning high-fat diet-induced nonalcoholic fatty liver disease via renin-angiotensin system","volume":"17","author":"Tiao","year":"2018","journal-title":"Lipids Health Dis"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2010.391","article-title":"Role of adipose tissue renin-angiotensin system in metabolic and inflammatory diseases associated with obesity","volume":"79","author":"Yvan-Charvet","year":"2011","journal-title":"Kidney Int"},{"key":"B37","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1089\/ars.2010.3795","article-title":"Mitochondria and redox signaling in steatohepatitis","volume":"15","author":"Morris","year":"2011","journal-title":"Antioxid Redox Signaling"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1101507108","article-title":"Identification and characterization of a functional mitochondrial angiotensin system","volume":"108","author":"Abadir","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"B39","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/S0009-9260(05)80350-2","article-title":"Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease","volume":"43","author":"Joseph","year":"1991","journal-title":"Clin Radiol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.565714\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T01:37:33Z","timestamp":1619141853000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.565714\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,22]]},"references-count":39,"alternative-id":["10.3389\/fendo.2021.565714"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2021.565714","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,22]]},"article-number":"565714"}}